9948. Veralipride

Nomenclature

CAS number: 66644-81-3
5-(Aminosulfonyl)-2,3-dimethoxy-N-[[1-(2-propen-1-yl)-2-pyrrolidinyl]methyl]benzamide; N-[(1-allyl-2-pyrrolidinyl)methyl]-5-sulfamoyl-o-veratramide; LIR-1660; Agréal (Sanofi-Aventis); Agradil (Sanofi-Aventis).
C17H25N3O5S; mol wt 383.46.
C 53.25%, H 6.57%, N 10.96%, O 20.86%, S 8.36%.

Description and references

Dopamine D2-receptor antagonist. Prepn: NL 7707982 (1978 to Soc. d'Etudes Sci. Ind. de l'Ile-de-France), C.A. 89, 30768 (1978). Pharmacological studies: P. Bouyard et al., Sem. Hop. 56, 1475 (1980); J. C. Czyba, ibid. 1483. Clinical studies: R. Renaud, J. Macler, ibid. 57, 353 (1981); S. Angeli, P. Fougère, ibid. 58, 111 (1982). Review of safety and tolerability: V. De Leo et al., Expert Opin. Drug Saf. 5, 695-701 (2006).

Chemical structure

Therapeutic Category

Treatment of menopausal disorders.

Keywords

Dopamine Receptor Antagonist